6.43%QQQQ 31.68 5.74%INTC 15.57 2.26%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - Covidien Ltd., a healthcare products manufacturer, said on Tuesday that its Procedure Kit for laparoscopic procedures was approved by U.S. regulators.
| COV | 44.72 |  -2.92 |
The Food and Drug Administration gave the green light to Covidien's SILS kit for Single-Incision Laparoscopic Surgery, which can be used to perform laparoscopic procedures through a single skin incision on the belly button.
"We led the first surgical revolution with multi-port laparoscopic surgery, and we are innovators once again with SILS, which offers surgeons an immediate advancement in patient care by minimizing scarring and pain" said Scott Flora, President of Covidien's Surgical Devices in a press release.
The product will be launched to the market in the summer of 2008. Shares of Covidien were lastly trading 0.77 percent down to $49.12 in the New York Stock Exchange on Tuesday.
Investor Julian Roberts believes the poor economy could last as long as 10 to 15 years, according to CNBC.
Joey Chestnut set a new fast-eating record when he ate 45 pizza slices in 10 min...
Oil prices rebounded from a 13-month low to rise above $81 a barrel Monday in As...
|
Get your next web design project done with our los angeles web design team - Best web design with great price.
|
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
